Search Results - "Lopez Broseta, PA"

4CPS-173 Pharmaceutical intervention in broad-spectrum antibiotic prescription in hospitalised patients by Sacanella Angles, I, Lopez Broseta, PA, Sanjuan Belda, A, Lloret Llorca, A, Garcia Pardo, G, Mendoza Aguilera, M, Roch Ventura, MA, Esteve Pitarch, E, Hernández, JDLMBoada, Canadell Vilarrasa, L

“…Background and importanceIndiscriminate use of broad-spectrum antibiotics implies a threat to public health and may cause multidrug-resistant pathogen…”
Get full text

4CPS-124 Adherence to selective immunosuppressive drug treatments in patients with inflammatory immune mediated diseases by López Broseta, PA, Del Estal Jiménez, J, Ventura, MÁ Roch, Sanjuan Belda, A, Jornet Montaña, S, Martín Marqués, M, Mendoza Aguilera, M, Esteve Pitarch, E, Vuelta Arce, M, Canadell Vilarrasa, L

“…Background and importanceThe paradigm of patients with immune mediated autoimmune diseases has changed with the introduction of biological medicines. The…”
Get full text

3PC-007 Levofloxacin 0.05% eye drops: a case study by Martín Marqués, M, De Dios López, A, Del Estal Jiménez, J, López Broseta, PA, Ventura, MÁ Roch, Sanjuan Belda, A, Jornet Montaña, S, Esteve Pitarch, E, Vuelta Arce, M, Mendoza Aguilera, M, Canadell Vilarrasa, L

“…Background and importanceBecause of the absence of appropriate pharmaceutical forms, pharmaceutical compounding is necessary in paediatric patients.Aim and…”
Get full text

4CPS-067 Analysis of usage of direct acting antivirals for the treatment of hepatitis C by Ventura, MÁ Roch, Del Estal Jiménez, J, Sanjuan Belda, A, Mendoza Aguilera, M, López Broseta, PA, Esteve Pitarch, E, Martín Marqués, M, Jornet Montaña, S, Vuelta Arce, M, Canadell Vilarrasa, L

“…Background and importanceThe approach to chronic hepatitis C (HCC) has changed. Treatments with more than 90% effectiveness, fixed length treatments, daily…”
Get full text

4CPS-044 Growth hormone therapy follow-up programme in paediatric patients by Jiménez, J del Estal, Marqués, M Martín, Montaña, S Jornet, Broseta, PA López, López, A de Dios, Parada, L Sánchez, Subirada, M Canela, Vilarrasa, LCanadell

“…BackgroundHormonal treatment can improve the clinical situation of child and adolescent patients because it enables them to reach an optimal height, and to…”
Get full text

PS-068 Analysis and improvement of prescription and administration in hospital transitions by Vilarrasa, L Canadell, Broseta, PA López, Parada, L Sánchez, Marqués, M Martín, López, A de Dios, Sirgo, G, Rodriguez, A, Esteban, F, Olona, M, Bodí, M

“…BackgroundAnticholinergic drugs (AchD) are often prescribed in elderly patients. They may increase cognitive and functional disorders, decrease the effects of…”
Get full text

CP-204 Observational study on the use of different therapeutic alternatives for multiple sclerosis treatment by de Dios López, A, Montaña, S Jornet, Parada, L Sánchez, Broseta, PA López, Marqués, M Martín, Subirada, M Canela

“…BackgroundMultiple sclerosis (MS) is a chronic demyelinating CNS disease. The recent commercialisation of new drugs for its treatment can change prescriber and…”
Get full text

CP-141 Venous thromboembolism prophylaxis adequacy of medical patients: cross sectional study by Vilarrasa, L Canadell, Broseta, PA López, Parada, L Sánchez, Marqués, M Martín, López, A De Dios, Subirada, M Canela

“…BackgroundVenous thromboembolism (VTE) in adults is associated with high morbidity and mortality. However, adherence to standards of prophylaxis care is not…”
Get full text

PS-076 Medication reconciliation programme in a third level hospital by Pou, J Torrent, Parada, L Sánchez, Vilarrasa, L Canadell, Marques, M Martin, Broseta, PA López, López, A De Dios, Subirada, M Canela

“…BackgroundMedication reconciliation (MR) is necessary to improve the continuity of medication between different levels of care, improving both safety and…”
Get full text